SiriusPoint (SPNT) is reshaping its operations into four business areas, including a combined Global P&C Programs division and a new London Market Specialty unit, signaling a fresh focus on programs and London specialty lines.
See our latest analysis for SiriusPoint.
The reorganization comes after a softer recent patch for the stock, with a 90 day share price return of a 7.24% decline and a year to date share price return of a 3.37% decline. This is in contrast with the 1 year total shareholder return of 34.75% and the 3 year total shareholder return of 178.14%, so recent momentum contrasts with stronger longer term gains.
If this kind of restructuring has you thinking about what else could be reshaping portfolios, it might be worth scanning for 20 top founder-led companies
With SiriusPoint trading at US$20.36 and sitting at an estimated 43% discount to one intrinsic value estimate, as well as below an average analyst price target of US$24.00, readers might ask whether there is a buying opportunity here or if the market is already pricing in future growth.
Most Popular Narrative: 15.2% Undervalued
With SiriusPoint shares at $20.36 against a most followed fair value estimate of $24.00, the key question is whether the underlying growth and margin story holds up.
The target moved from $27.50 to $24.00, indicating a moderate downward reset in the implied equity value per share. The assumed net profit margin moved from 11.25% to 6.88%, a significant cut that lowers the earnings power embedded in the model.
Analysts are now incorporating slower revenue growth, leaner margins and a different earnings multiple, yet still arrive at a higher fair value than today. Curious which specific shifts in growth, profitability and discount rate assumptions are doing the most to support that $24.00 number?
Result: Fair Value of $24.00 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the story could change quickly if MGA partnerships underperform or if catastrophe and reserve risks lead to unexpected claims hitting earnings and book value.
Find out about the key risks to this SiriusPoint narrative.
Next Steps
Given the mix of optimism and concern running through this story, it makes sense to move quickly and weigh the trade off yourself by checking the 3 key rewards and 2 important warning signs.
Looking for more investment ideas?
If SiriusPoint has you rethinking your portfolio, do not stop here; broaden your watchlist with stocks that match the kind of qualities you care about most.
- Target dependable cash generators by screening for companies with stronger balance sheets and fundamentals using the solid balance sheet and fundamentals stocks screener (42 results).
- Hunt for price mismatches by focusing on businesses that look attractively priced through the 49 high quality undervalued stocks.
- Prioritise income potential by zeroing in on higher yielding companies with the 14 dividend fortresses.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com